Molecular profiling in lung cancer specimens leads to targeted therapeutic options in patients with non-small cell lung carcinoma (NSCLC)
2013
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI